{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:11:09Z","timestamp":1790997069195,"version":"4.1.0"},"reference-count":234,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03843-y","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T10:06:42Z","timestamp":1762164402000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Non-coding RNAs-mediated regulation of the MAPK pathway in gastric cancer: translational perspectives"],"prefix":"10.1007","volume":"16","author":[{"given":"Darmadi","family":"Darmadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Komeil","family":"Aghazadeh-Habashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sona","family":"Ayvazyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshia","family":"Bozorgnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elnaz","family":"Khodabandehloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"issue":"3","key":"3843_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A cancer. J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"J Clin"},{"issue":"5","key":"3843_CR2","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1136\/jmedgenet-2016-104171","volume":"54","author":"X-y Zhang","year":"2017","unstructured":"Zhang X-y, Zhang P-y. Gastric cancer: somatic genetics as a guide to therapy. J Med Genet. 2017;54(5):305\u201312.","journal-title":"J Med Genet"},{"issue":"10251","key":"3843_CR3","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396(10251):635\u201348.","journal-title":"Lancet"},{"key":"3843_CR4","doi-asserted-by":"publisher","unstructured":"Iwu CD, Iwu-Jaja CJ. Gastric cancer epidemiology: current trend and future direction. Hygiene. 2023;3(3), 256\u201368. https:\/\/doi.org\/10.3390\/hygiene3030019.","DOI":"10.3390\/hygiene3030019"},{"issue":"3","key":"3843_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"3843_CR6","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"issue":"5\u20136","key":"3843_CR7","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1080\/15216540600746393","volume":"58","author":"M Imajo","year":"2006","unstructured":"Imajo M, Tsuchiya Y, Nishida E. Regulatory mechanisms and functions of MAP kinase signaling pathways. IUBMB Life. 2006;58(5\u20136):312\u20137.","journal-title":"IUBMB Life"},{"key":"3843_CR8","doi-asserted-by":"publisher","first-page":"106398","DOI":"10.1016\/j.phrs.2022.106398","volume":"184","author":"J Anjum","year":"2022","unstructured":"Anjum J, Mitra S, Das R, Alam R, Mojumder A, Emran TB, et al. A renewed concept on the MAPK signaling pathway in cancers: polyphenols as a choice of therapeutics. Pharmacol Res. 2022;184:106398. https:\/\/doi.org\/10.1016\/j.phrs.2022.106398.","journal-title":"Pharmacol Res"},{"key":"3843_CR9","doi-asserted-by":"publisher","unstructured":"Ferlier T, Coulouarn C. Regulation of gene expression in Cancer-an overview. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11244058.","DOI":"10.3390\/cells11244058"},{"issue":"10","key":"3843_CR10","doi-asserted-by":"publisher","first-page":"e15705","DOI":"10.15252\/emmm.202215705","volume":"14","author":"T Seidlitz","year":"2022","unstructured":"Seidlitz T, Schm\u00e4che T, Garc\u03afa F, Lee JH, Qin N, Kochall S, et al. Sensitivity towards HDAC Inhibition is associated with RTK\/MAPK pathway activation in gastric cancer. EMBO Mol Med. 2022;14(10):e15705. https:\/\/doi.org\/10.15252\/emmm.202215705.","journal-title":"EMBO Mol Med"},{"issue":"2","key":"3843_CR11","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41401-023-01165-9","volume":"45","author":"J-x Xiong","year":"2024","unstructured":"Xiong J-x, Li Y-t, Tan X-y, Chen T, Liu B-h. Targeting PRSS23 with Tipranavir induces gastric cancer stem cell apoptosis and inhibits growth of gastric cancer via the MKK3\/p38 MAPK-IL24 pathway. Acta Pharmacol Sin. 2024;45(2):405\u201321. https:\/\/doi.org\/10.1038\/s41401-023-01165-9.","journal-title":"Acta Pharmacol Sin"},{"issue":"8","key":"3843_CR12","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1097\/cm9.0000000000000742","volume":"133","author":"ZY Yu","year":"2020","unstructured":"Yu ZY, Jiang XY, Zhao RR, Qin JJ, Luo CJ, Ren YX, et al. Effect of KIF22 on promoting proliferation and migration of gastric cancer cells via MAPK-ERK pathways. Chin Med J (Engl). 2020;133(8):919\u201328. https:\/\/doi.org\/10.1097\/cm9.0000000000000742.","journal-title":"Chin Med J (Engl)"},{"issue":"7","key":"3843_CR13","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41591-018-0022-x","volume":"24","author":"GS Wong","year":"2018","unstructured":"Wong GS, Zhou J, Liu JB, Wu Z, Xu X, Li T, et al. Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 Inhibition. Nat Med. 2018;24(7):968\u201377. https:\/\/doi.org\/10.1038\/s41591-018-0022-x.","journal-title":"Nat Med"},{"issue":"1","key":"3843_CR14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1053\/j.gastro.2023.09.040","volume":"166","author":"H Kim","year":"2024","unstructured":"Kim H, Jang B, Zhang C, Caldwell B, Park DJ, Kong SH, et al. Targeting stem cells and dysplastic features with dual MEK\/ERK and STAT3 suppression in gastric carcinogenesis. Gastroenterology. 2024;166(1):117\u201331. https:\/\/doi.org\/10.1053\/j.gastro.2023.09.040.","journal-title":"Gastroenterology"},{"key":"3843_CR15","doi-asserted-by":"publisher","unstructured":"Soni DK, Biswas R. Role of Non-Coding RNAs in Post-Transcriptional regulation of lung diseases. Front Genet. 2021. https:\/\/doi.org\/10.3389\/fgene.2021.767348.","DOI":"10.3389\/fgene.2021.767348"},{"key":"3843_CR16","doi-asserted-by":"publisher","unstructured":"Liu Y, Ao X, Wang Y, Li X, Wang J. Long Non-Coding RNA in gastric cancer: mechanisms and clinical implications for drug resistance. Front Oncol. 2022. https:\/\/doi.org\/10.3389\/fonc.2022.841411.","DOI":"10.3389\/fonc.2022.841411"},{"issue":"7","key":"3843_CR17","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.2174\/138161213804805621","volume":"19","author":"HW Pan","year":"2013","unstructured":"Pan HW, Li SC, Tsai KW. MicroRNA dysregulation in gastric cancer. Curr Pharm Des. 2013;19(7):1273\u201384. https:\/\/doi.org\/10.2174\/138161213804805621.","journal-title":"Curr Pharm Des"},{"issue":"11","key":"3843_CR18","doi-asserted-by":"publisher","first-page":"e1000176","DOI":"10.1371\/journal.pcbi.1000176","volume":"4","author":"ME Dinger","year":"2008","unstructured":"Dinger ME, Pang KC, Mercer TR, Mattick JS. Differentiating protein-coding and noncoding RNA: challenges and ambiguities. PLoS Comput Biol. 2008;4(11):e1000176.","journal-title":"PLoS Comput Biol"},{"key":"3843_CR19","doi-asserted-by":"publisher","unstructured":"Karakas D, Ozpolat B. The role of LncRNAs in translation. Noncoding RNA. 2021. https:\/\/doi.org\/10.3390\/ncrna7010016.","DOI":"10.3390\/ncrna7010016"},{"issue":"1","key":"3843_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ncrna.2016.11.002","volume":"1","author":"SA Bhat","year":"2016","unstructured":"Bhat SA, Ahmad SM, Mumtaz PT, Malik AA, Dar MA, Urwat U, et al. Long non-coding rnas: mechanism of action and functional utility. Non-coding RNA Res. 2016;1(1):43\u201350. https:\/\/doi.org\/10.1016\/j.ncrna.2016.11.002.","journal-title":"Non-coding RNA Res"},{"issue":"1","key":"3843_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrg3606","volume":"15","author":"A Fatica","year":"2014","unstructured":"Fatica A, Bozzoni I. Long non-coding rnas: new players in cell differentiation and development. Nat Rev Genet. 2014;15(1):7\u201321. https:\/\/doi.org\/10.1038\/nrg3606.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"3843_CR22","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s12672-025-02888-3","volume":"16","author":"Y Metanat","year":"2025","unstructured":"Metanat Y, Sviridova M, Al-Nuaimi BN, Janbazi F, Jalali M, Ghalamkarpour N, et al. The role of non-coding RNAs in the regulation of cell death pathways in melanoma. Discover Oncol. 2025;16(1):1063. https:\/\/doi.org\/10.1007\/s12672-025-02888-3.","journal-title":"Discover Oncol"},{"key":"3843_CR23","doi-asserted-by":"publisher","unstructured":"Wang Q, Feng J, Tang L, Non-Coding RNA. Related to MAPK signaling pathway in liver cancer. Int J Mol Sci. 2022;23(19). https:\/\/doi.org\/10.3390\/ijms231911908.","DOI":"10.3390\/ijms231911908"},{"issue":"1","key":"3843_CR24","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1186\/s12967-023-04434-7","volume":"21","author":"A Maharati","year":"2023","unstructured":"Maharati A, Moghbeli M. Long non-coding RNAs as the critical regulators of PI3K\/AKT, TGF-\u03b2, and MAPK signaling pathways during breast tumor progression. J Translational Med. 2023;21(1):556. https:\/\/doi.org\/10.1186\/s12967-023-04434-7.","journal-title":"J Translational Med"},{"issue":"41","key":"3843_CR25","doi-asserted-by":"publisher","first-page":"11673","DOI":"10.3748\/wjg.v21.i41.11673","volume":"21","author":"M Yang","year":"2015","unstructured":"Yang M, Huang CZ. Mitogen-activated protein kinase signaling pathway and invasion and metastasis of gastric cancer. World J Gastroenterol. 2015;21(41):11673\u20139. https:\/\/doi.org\/10.3748\/wjg.v21.i41.11673.","journal-title":"World J Gastroenterol"},{"issue":"7pt2","key":"3843_CR26","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1111\/j.1440-1746.2007.04912.x","volume":"23","author":"SZ Ding","year":"2008","unstructured":"Ding SZ, Smith MF Jr, Goldberg JB. Helicobacter pylori and mitogen-activated protein kinases regulate the cell cycle, proliferation and apoptosis in gastric epithelial cells. J Gastroenterol Hepatol. 2008;23(7pt2):e67\u201378.","journal-title":"J Gastroenterol Hepatol"},{"key":"3843_CR27","doi-asserted-by":"publisher","unstructured":"Wang J, Liu T, Huang T, Shang M, Wang X. The mechanisms on evasion of anti-tumor immune responses in gastric cancer. Front Oncol. 2022. https:\/\/doi.org\/10.3389\/fonc.2022.943806.","DOI":"10.3389\/fonc.2022.943806"},{"key":"3843_CR28","doi-asserted-by":"publisher","unstructured":"Nienh\u00fcser H, Schmidt T. Angiogenesis and Anti-Angiogenic therapy in gastric cancer. Int J Mol Sci. 2017;19(1). https:\/\/doi.org\/10.3390\/ijms19010043.","DOI":"10.3390\/ijms19010043"},{"issue":"3","key":"3843_CR29","doi-asserted-by":"publisher","first-page":"188736","DOI":"10.1016\/j.bbcan.2022.188736","volume":"1877","author":"H-B Park","year":"2022","unstructured":"Park H-B, Baek K-H. E3 ligases and deubiquitinating enzymes regulating the MAPK signaling pathway in cancers. Biochim Et Biophys Acta (BBA)-Reviews Cancer. 2022;1877(3):188736.","journal-title":"Biochim Et Biophys Acta (BBA)-Reviews Cancer"},{"issue":"22","key":"3843_CR30","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1038\/sj.onc.1210409","volume":"26","author":"B Cuevas","year":"2007","unstructured":"Cuevas B, Abell A, Johnson G. Role of mitogen-activated protein kinase kinase kinases in signal integration. Oncogene. 2007;26(22):3159\u201371.","journal-title":"Oncogene"},{"key":"3843_CR31","doi-asserted-by":"publisher","unstructured":"Morrison DK. MAP kinase pathways. Cold Spring Harb Perspect Biol. 2012;4(11). https:\/\/doi.org\/10.1101\/cshperspect.a011254.","DOI":"10.1101\/cshperspect.a011254"},{"issue":"1","key":"3843_CR32","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/0092-8674(82)90426-3","volume":"31","author":"JA Cooper","year":"1982","unstructured":"Cooper JA, Bowen-Pope DF, Raines E, Ross R, Hunter T. Similar effects of platelet-derived growth factor and epidermal growth factor on the phosphorylation of tyrosine in cellular proteins. Cell. 1982;31(1):263\u201373.","journal-title":"Cell"},{"issue":"4","key":"3843_CR33","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1083\/jcb.106.4.1395","volume":"106","author":"A Kazlauskas","year":"1988","unstructured":"Kazlauskas A, Cooper JA. Protein kinase C mediates platelet-derived growth factor-induced tyrosine phosphorylation of p42. J Cell Biol. 1988;106(4):1395\u2013402.","journal-title":"J Cell Biol"},{"issue":"4964","key":"3843_CR34","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1126\/science.2164259","volume":"249","author":"TG Boulton","year":"1990","unstructured":"Boulton TG, Yancopoulos GD, Gregory JS, Slaughter C, Moomaw C, Hsu J, et al. An insulin-stimulated protein kinase similar to yeast kinases involved in cell cycle control. Science. 1990;249(4964):64\u20137.","journal-title":"Science"},{"issue":"22","key":"3843_CR35","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1038\/sj.onc.1210392","volume":"26","author":"M Raman","year":"2007","unstructured":"Raman M, Chen W, Cobb M. Differential regulation and properties of MAPKs. Oncogene. 2007;26(22):3100\u201312.","journal-title":"Oncogene"},{"issue":"1","key":"3843_CR36","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1128\/mmbr.00031-10","volume":"75","author":"M Cargnello","year":"2011","unstructured":"Cargnello M, Roux PP. Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev. 2011;75(1):50\u201383. https:\/\/doi.org\/10.1128\/mmbr.00031-10.","journal-title":"Microbiol Mol Biol Rev"},{"issue":"22","key":"3843_CR37","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1038\/sj.onc.1210394","volume":"26","author":"M McKay","year":"2007","unstructured":"McKay M, Morrison D. Integrating signals from RTKs to ERK\/MAPK. Oncogene. 2007;26(22):3113\u201321.","journal-title":"Oncogene"},{"issue":"8","key":"3843_CR38","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.bbamcr.2006.10.005","volume":"1773","author":"YD Shaul","year":"2007","unstructured":"Shaul YD, Seger R. The MEK\/ERK cascade: from signaling specificity to diverse functions. Biochim Et Biophys Acta (BBA)-Molecular Cell Res. 2007;1773(8):1213\u201326.","journal-title":"Biochim Et Biophys Acta (BBA)-Molecular Cell Res"},{"key":"3843_CR39","doi-asserted-by":"publisher","unstructured":"Yue J, L\u00f3pez JM. Understanding MAPK signaling pathways in apoptosis. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21072346.","DOI":"10.3390\/ijms21072346"},{"issue":"1","key":"3843_CR40","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41392-023-01705-z","volume":"8","author":"ME Bahar","year":"2023","unstructured":"Bahar ME, Kim HJ, Kim DR. Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies. Signal Transduct Target Ther. 2023;8(1):455. https:\/\/doi.org\/10.1038\/s41392-023-01705-z.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"3843_CR41","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1097\/js9.0000000000001051","volume":"110","author":"A Fareed","year":"2024","unstructured":"Fareed A, Amir N, Ajaz H, Sohail A, Vaid R, Farhat S. Advances in BRAF-targeted therapies for non-small cell lung cancer: the promise of Encorafenib and binimetinib. Int J Surg. 2024;110(4):1891\u20133. https:\/\/doi.org\/10.1097\/js9.0000000000001051.","journal-title":"Int J Surg"},{"issue":"1","key":"3843_CR42","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41467-022-35592-9","volume":"14","author":"WK Chatila","year":"2023","unstructured":"Chatila WK, Walch H, Hechtman JF, Moyer SM, Sgambati V, Faleck DM, et al. Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers. Nat Commun. 2023;14(1):110. https:\/\/doi.org\/10.1038\/s41467-022-35592-9.","journal-title":"Nat Commun"},{"issue":"1","key":"3843_CR43","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1038\/s41467-018-03828-2","volume":"9","author":"YA Guo","year":"2018","unstructured":"Guo YA, Chang MM, Huang W, Ooi WF, Xing M, Tan P, et al. Mutation hotspots at CTCF binding sites coupled to chromosomal instability in Gastrointestinal cancers. Nat Commun. 2018;9(1):1520. https:\/\/doi.org\/10.1038\/s41467-018-03828-2.","journal-title":"Nat Commun"},{"issue":"5","key":"3843_CR44","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/s41591-023-02324-5","volume":"29","author":"J Roelands","year":"2023","unstructured":"Roelands J, Kuppen PJK, Ahmed EI, Mall R, Masoodi T, Singh P, et al. An integrated tumor, immune and Microbiome atlas of colon cancer. Nat Med. 2023;29(5):1273\u201386. https:\/\/doi.org\/10.1038\/s41591-023-02324-5.","journal-title":"Nat Med"},{"issue":"8","key":"3843_CR45","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.bbamcr.2006.12.009","volume":"1773","author":"GL Johnson","year":"2007","unstructured":"Johnson GL, Nakamura K. The c-jun kinase\/stress-activated pathway: regulation, function and role in human disease. Biochim Et Biophys Acta (BBA)-Molecular Cell Res. 2007;1773(8):1341\u20138.","journal-title":"Biochim Et Biophys Acta (BBA)-Molecular Cell Res"},{"issue":"25","key":"3843_CR46","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/S0960-9822(98)00019-0","volume":"8","author":"S Lawler","year":"1998","unstructured":"Lawler S, Fleming Y, Goedert M, Cohen P. Synergistic activation of SAPK1\/JNK1 by two MAP kinase kinases in vitro. Curr Biol. 1998;8(25):1387\u201391.","journal-title":"Curr Biol"},{"issue":"8","key":"3843_CR47","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrc2694","volume":"9","author":"EF Wagner","year":"2009","unstructured":"Wagner EF, Nebreda \u00c1R. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer. 2009;9(8):537\u201349.","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"3843_CR48","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.molcel.2006.07.028","volume":"23","author":"A Jaeschke","year":"2006","unstructured":"Jaeschke A, Karasarides M, Ventura J-J, Ehrhardt A, Zhang C, Flavell RA, et al. JNK2 is a positive regulator of the cJun transcription factor. Mol Cell. 2006;23(6):899\u2013911.","journal-title":"Mol Cell"},{"key":"3843_CR49","doi-asserted-by":"crossref","unstructured":"Bogoyevitch MA, Ngoei KR, Zhao TT, Yeap YY, Ng DC. c-Jun N-terminal kinase (JNK) signaling: recent advances and challenges. Biochimica et biophysica acta (BBA)-Proteins and proteomics. 2010;1804(3):463\u201375.","DOI":"10.1016\/j.bbapap.2009.11.002"},{"issue":"48","key":"3843_CR50","doi-asserted-by":"publisher","first-page":"6245","DOI":"10.1038\/onc.2008.301","volume":"27","author":"DN Dhanasekaran","year":"2008","unstructured":"Dhanasekaran DN, Reddy EP. JNK signaling in apoptosis. Oncogene. 2008;27(48):6245\u201351.","journal-title":"Oncogene"},{"issue":"3","key":"3843_CR51","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.cyto.2009.08.002","volume":"48","author":"G Huang","year":"2009","unstructured":"Huang G, Shi LZ, Chi H. Regulation of JNK and p38 MAPK in the immune system: signal integration, propagation and termination. Cytokine. 2009;48(3):161\u20139.","journal-title":"Cytokine"},{"issue":"1","key":"3843_CR52","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1600-065X.2008.00744.x","volume":"228","author":"M Rinc\u00f3n","year":"2009","unstructured":"Rinc\u00f3n M, Davis RJ. Regulation of the immune response by stress-activated protein kinases. Immunol Rev. 2009;228(1):212\u201324.","journal-title":"Immunol Rev"},{"issue":"3","key":"3843_CR53","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1042\/BJ20100323","volume":"429","author":"A Cuadrado","year":"2010","unstructured":"Cuadrado A, Nebreda AR. Mechanisms and functions of p38 MAPK signalling. Biochem J. 2010;429(3):403\u201317.","journal-title":"Biochem J"},{"issue":"30","key":"3843_CR54","doi-asserted-by":"publisher","first-page":"17920","DOI":"10.1074\/jbc.271.30.17920","volume":"271","author":"Y Jiang","year":"1996","unstructured":"Jiang Y, Chen C, Li Z, Guo W, Gegner JA, Lin S, et al. Characterization of the structure and function of a new mitogen-activated protein kinase (p38\u03b2). J Biol Chem. 1996;271(30):17920\u20136.","journal-title":"J Biol Chem"},{"issue":"8","key":"3843_CR55","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.bbamcr.2007.03.010","volume":"1773","author":"A Cuenda","year":"2007","unstructured":"Cuenda A, Rousseau S. p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim Et Biophys Acta (BBA)-Molecular Cell Res. 2007;1773(8):1358\u201375.","journal-title":"Biochim Et Biophys Acta (BBA)-Molecular Cell Res"},{"key":"3843_CR56","doi-asserted-by":"publisher","unstructured":"Magnelli L, Schiavone N, Staderini F, Biagioni A, Papucci L. MAP kinases pathways in gastric cancer. Int J Mol Sci. 2020;21(8). https:\/\/doi.org\/10.3390\/ijms21082893.","DOI":"10.3390\/ijms21082893"},{"issue":"5","key":"3843_CR57","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1136\/gutjnl-2011-301839","volume":"61","author":"N Deng","year":"2012","unstructured":"Deng N, Goh LK, Wang H, Das K, Tao J, Tan IB, et al. A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets. Gut. 2012;61(5):673\u201384. https:\/\/doi.org\/10.1136\/gutjnl-2011-301839.","journal-title":"Gut"},{"key":"3843_CR58","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/82_2011_162","volume":"355","author":"CA Pratilas","year":"2012","unstructured":"Pratilas CA, Xing F, Solit DB. Targeting oncogenic BRAF in human cancer. Curr Top Microbiol Immunol. 2012;355:83\u201398. https:\/\/doi.org\/10.1007\/82_2011_162.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"8","key":"3843_CR59","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.1007\/s13277-015-3282-9","volume":"36","author":"H Akter","year":"2015","unstructured":"Akter H, Park M, Kwon OS, Song EJ, Park WS, Kang MJ. Activation of matrix metalloproteinase-9 (MMP-9) by neurotensin promotes cell invasion and migration through ERK pathway in gastric cancer. Tumour Biol. 2015;36(8):6053\u201362. https:\/\/doi.org\/10.1007\/s13277-015-3282-9.","journal-title":"Tumour Biol"},{"issue":"1","key":"3843_CR60","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1756-9966-31-30","volume":"31","author":"Y Fujimori","year":"2012","unstructured":"Fujimori Y, Inokuchi M, Takagi Y, Kato K, Kojima K, Sugihara K. Prognostic value of RKIP and p-ERK in gastric cancer. J Exp Clin Cancer Res. 2012;31(1):30. https:\/\/doi.org\/10.1186\/1756-9966-31-30.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"3843_CR61","doi-asserted-by":"publisher","first-page":"11127","DOI":"10.1038\/s41598-017-11769-x","volume":"7","author":"K Baba","year":"2017","unstructured":"Baba K, Kitajima Y, Miyake S, Nakamura J, Wakiyama K, Sato H, et al. Hypoxia-induced ANGPTL4 sustains tumour growth and Anoikis resistance through different mechanisms in scirrhous gastric cancer cell lines. Sci Rep. 2017;7(1):11127. https:\/\/doi.org\/10.1038\/s41598-017-11769-x.","journal-title":"Sci Rep"},{"key":"3843_CR62","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/1471-2407-8-375","volume":"8","author":"X Guo","year":"2008","unstructured":"Guo X, Ma N, Wang J, Song J, Bu X, Cheng Y, et al. Increased p38-MAPK is responsible for chemotherapy resistance in human gastric cancer cells. BMC Cancer. 2008;8:375. https:\/\/doi.org\/10.1186\/1471-2407-8-375.","journal-title":"BMC Cancer"},{"issue":"4","key":"3843_CR63","first-page":"1604","volume":"61","author":"QB She","year":"2001","unstructured":"She QB, Bode AM, Ma WY, Chen NY, Dong Z. Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res. 2001;61(4):1604\u201310.","journal-title":"Cancer Res"},{"issue":"2","key":"3843_CR64","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/sj.onc.1204062","volume":"20","author":"SS Bacus","year":"2001","unstructured":"Bacus SS, Gudkov AV, Lowe M, Lyass L, Yung Y, Komarov AP, et al. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53. Oncogene. 2001;20(2):147\u201355. https:\/\/doi.org\/10.1038\/sj.onc.1204062.","journal-title":"Oncogene"},{"issue":"6","key":"3843_CR65","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/ng2033","volume":"39","author":"L Hui","year":"2007","unstructured":"Hui L, Bakiri L, Mairhorfer A, Schweifer N, Haslinger C, Kenner L, et al. p38alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway. Nat Genet. 2007;39(6):741\u20139. https:\/\/doi.org\/10.1038\/ng2033.","journal-title":"Nat Genet"},{"issue":"5","key":"3843_CR66","first-page":"1343","volume":"62","author":"QB She","year":"2002","unstructured":"She QB, Chen N, Bode AM, Flavell RA, Dong Z. Deficiency of c-Jun-NH(2)-terminal kinase-1 in mice enhances skin tumor development by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 2002;62(5):1343\u20138.","journal-title":"Cancer Res"},{"issue":"2","key":"3843_CR67","first-page":"199","volume":"22","author":"R Ono","year":"2008","unstructured":"Ono R, Matsuoka J, Yamatsuji T, Naomoto Y, Tanaka N, Matsui H, et al. M-RIP, a novel target of JNK signaling and a requirement for human cancer cell invasion. Int J Mol Med. 2008;22(2):199\u2013203.","journal-title":"Int J Mol Med"},{"issue":"2","key":"3843_CR68","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/sj.onc.1207147","volume":"23","author":"AM Mingo-Sion","year":"2004","unstructured":"Mingo-Sion AM, Marietta PM, Koller E, Wolf DM, Van Den Berg CL. Inhibition of JNK reduces G2\/M transit independent of p53, leading to endoreduplication, decreased proliferation, and apoptosis in breast cancer cells. Oncogene. 2004;23(2):596\u2013604. https:\/\/doi.org\/10.1038\/sj.onc.1207147.","journal-title":"Oncogene"},{"issue":"1","key":"3843_CR69","first-page":"391","volume":"9","author":"YM Yang","year":"2003","unstructured":"Yang YM, Bost F, Charbono W, Dean N, McKay R, Rhim JS, et al. C-Jun NH(2)-terminal kinase mediates proliferation and tumor growth of human prostate carcinoma. Clin Cancer Res. 2003;9(1):391\u2013401.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"3843_CR70","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.canlet.2005.10.031","volume":"241","author":"HH-X Xia","year":"2006","unstructured":"Xia HH-X, He H, Wang JD, Gu Q, Lin MCM, Zou B, et al. Induction of apoptosis and cell cycle arrest by a specific c-Jun NH2-terminal kinase (JNK) inhibitor, SP-600125, in Gastrointestinal cancers. Cancer Lett. 2006;241(2):268\u201374. https:\/\/doi.org\/10.1016\/j.canlet.2005.10.031.","journal-title":"Cancer Lett"},{"issue":"1","key":"3843_CR71","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41392-022-01190-w","volume":"7","author":"ZN Lei","year":"2022","unstructured":"Lei ZN, Teng QX, Tian Q, Chen W, Xie Y, Wu K, et al. Signaling pathways and therapeutic interventions in gastric cancer. Signal Transduct Target Ther. 2022;7(1):358. https:\/\/doi.org\/10.1038\/s41392-022-01190-w.","journal-title":"Signal Transduct Target Ther"},{"issue":"13","key":"3843_CR72","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.1158\/0008-5472.Can-07-6332","volume":"68","author":"W Shibata","year":"2008","unstructured":"Shibata W, Maeda S, Hikiba Y, Yanai A, Sakamoto K, Nakagawa H, et al. c-Jun NH2-terminal kinase 1 is a critical regulator for the development of gastric cancer in mice. Cancer Res. 2008;68(13):5031\u20139. https:\/\/doi.org\/10.1158\/0008-5472.Can-07-6332.","journal-title":"Cancer Res"},{"issue":"6","key":"3843_CR73","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.3748\/wjg.v8.i6.1014","volume":"8","author":"Y Chen","year":"2002","unstructured":"Chen Y, Wu Q, Song SY, Su WJ. Activation of JNK by TPA promotes apoptosis via PKC pathway in gastric cancer cells. World J Gastroenterol. 2002;8(6):1014\u20138. https:\/\/doi.org\/10.3748\/wjg.v8.i6.1014.","journal-title":"World J Gastroenterol"},{"issue":"8","key":"3843_CR74","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3748\/wjg.v10.i8.1110","volume":"10","author":"K Wu","year":"2004","unstructured":"Wu K, Zhao Y, Li GC, Yu WP. c-Jun N-terminal kinase is required for vitamin E succinate-induced apoptosis in human gastric cancer cells. World J Gastroenterol. 2004;10(8):1110\u20134. https:\/\/doi.org\/10.3748\/wjg.v10.i8.1110.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"3843_CR75","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.canlet.2006.05.015","volume":"247","author":"Y Zhao","year":"2007","unstructured":"Zhao Y, Zhao X, Yang B, Neuzil J, Wu K. alpha-Tocopheryl succinate-induced apoptosis in human gastric cancer cells is modulated by ERK1\/2 and c-Jun N-terminal kinase in a biphasic manner. Cancer Lett. 2007;247(2):345\u201352. https:\/\/doi.org\/10.1016\/j.canlet.2006.05.015.","journal-title":"Cancer Lett"},{"issue":"10","key":"3843_CR76","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1007\/s10495-011-0629-6","volume":"16","author":"R Kannaiyan","year":"2011","unstructured":"Kannaiyan R, Manu KA, Chen L, Li F, Rajendran P, Subramaniam A, et al. Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3 K\/Akt signaling pathways. Apoptosis. 2011;16(10):1028\u201341. https:\/\/doi.org\/10.1007\/s10495-011-0629-6.","journal-title":"Apoptosis"},{"issue":"48","key":"3843_CR77","doi-asserted-by":"publisher","first-page":"7348","DOI":"10.3748\/wjg.v18.i48.7348","volume":"18","author":"F Xiao","year":"2012","unstructured":"Xiao F, Liu B, Zhu QX. c-Jun N-terminal kinase is required for thermotherapy-induced apoptosis in human gastric cancer cells. World J Gastroenterol. 2012;18(48):7348\u201356. https:\/\/doi.org\/10.3748\/wjg.v18.i48.7348.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"3843_CR78","first-page":"745","volume":"17","author":"JY Yan","year":"2013","unstructured":"Yan JY, Tian FM, Hu WN, Zhang JH, Cai HF, Li N. Apoptosis of human gastric cancer cells line SGC 7901 induced by garlic-derived compound S-allylmercaptocysteine (SAMC). Eur Rev Med Pharmacol Sci. 2013;17(6):745\u201351.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3843_CR79","doi-asserted-by":"publisher","unstructured":"Zhang P, Wu W, Chen Q, Chen M. Non-Coding RNAs and their integrated networks. J Integr Bioinform. 2019;16(3). https:\/\/doi.org\/10.1515\/jib-2019-0027.","DOI":"10.1515\/jib-2019-0027"},{"key":"3843_CR80","doi-asserted-by":"publisher","first-page":"145300","DOI":"10.1016\/j.gene.2020.145300","volume":"768","author":"Z Hongkuan","year":"2021","unstructured":"Hongkuan Z, Karsoon T, Shengkang L, Hongyu M, Huaiping Z. The functional roles of the non-coding RNAs in molluscs. Gene. 2021;768:145300. https:\/\/doi.org\/10.1016\/j.gene.2020.145300.","journal-title":"Gene"},{"issue":"12","key":"3843_CR81","doi-asserted-by":"publisher","first-page":"241","DOI":"10.21037\/atm.2018.06.10","volume":"6","author":"MA Diamantopoulos","year":"2018","unstructured":"Diamantopoulos MA, Tsiakanikas P, Scorilas A. Non-coding rnas: the riddle of the transcriptome and their perspectives in cancer. Ann Transl Med. 2018;6(12):241. https:\/\/doi.org\/10.21037\/atm.2018.06.10.","journal-title":"Ann Transl Med"},{"issue":"5","key":"3843_CR82","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","volume":"75","author":"RC Lee","year":"1993","unstructured":"Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75(5):843\u201354.","journal-title":"Cell"},{"issue":"5","key":"3843_CR83","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/0092-8674(93)90530-4","volume":"75","author":"B Wightman","year":"1993","unstructured":"Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates Temporal pattern formation in C. elegans. Cell. 1993;75(5):855\u201362.","journal-title":"Cell"},{"issue":"D1","key":"3843_CR84","doi-asserted-by":"publisher","first-page":"D155","DOI":"10.1093\/nar\/gky1141","volume":"47","author":"A Kozomara","year":"2019","unstructured":"Kozomara A, Birgaoanu M, Griffiths-Jones S. MiRBase: from MicroRNA sequences to function. Nucleic Acids Res. 2019;47(D1):D155\u201362. https:\/\/doi.org\/10.1093\/nar\/gky1141.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3843_CR85","doi-asserted-by":"publisher","first-page":"15004","DOI":"10.1038\/sigtrans.2015.4","volume":"1","author":"Y Peng","year":"2016","unstructured":"Peng Y, Croce CM. The role of MicroRNAs in human cancer. Signal Transduct Target Therapy. 2016;1(1):15004. https:\/\/doi.org\/10.1038\/sigtrans.2015.4.","journal-title":"Signal Transduct Target Therapy"},{"issue":"9","key":"3843_CR86","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/nbt.3947","volume":"35","author":"D De Rie","year":"2017","unstructured":"De Rie D, Abugessaisa I, Alam T, Arner E, Arner P, Ashoor H, et al. An integrated expression atlas of MiRNAs and their promoters in human and mouse. Nat Biotechnol. 2017;35(9):872\u20138.","journal-title":"Nat Biotechnol"},{"issue":"3","key":"3843_CR87","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/sj.emboj.7601512","volume":"26","author":"YK Kim","year":"2007","unstructured":"Kim YK, Kim VN. Processing of intronic MicroRNAs. EMBO J. 2007;26(3):775\u201383.","journal-title":"EMBO J"},{"key":"3843_CR88","doi-asserted-by":"crossref","unstructured":"Vishnoi A, Rani S. MiRNA biogenesis and regulation of diseases: an overview. MicroRNA Profiling: Methods Protocols. 2017:1\u201310.","DOI":"10.1007\/978-1-4939-6524-3_1"},{"issue":"1","key":"3843_CR89","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/ncrna8010010","volume":"8","author":"AL Leit\u00e3o","year":"2022","unstructured":"Leit\u00e3o AL, Enguita FJ. A structural view of MiRNA biogenesis and function. Non-coding RNA. 2022;8(1):10.","journal-title":"Non-coding RNA"},{"issue":"13","key":"3843_CR90","doi-asserted-by":"publisher","first-page":"4528","DOI":"10.1093\/jxb\/erac098","volume":"73","author":"H Pietrykowska","year":"2022","unstructured":"Pietrykowska H, Sierocka I, Zielezinski A, Alisha A, Carrasco-Sanchez JC, Jarmolowski A, et al. Biogenesis, conservation, and function of MiRNA in liverworts. J Exp Bot. 2022;73(13):4528\u201345.","journal-title":"J Exp Bot"},{"issue":"7014","key":"3843_CR91","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature03049","volume":"432","author":"AM Denli","year":"2004","unstructured":"Denli AM, Tops BB, Plasterk RH, Ketting RF, Hannon GJ. Processing of primary MicroRNAs by the microprocessor complex. Nature. 2004;432(7014):231\u20135.","journal-title":"Nature"},{"issue":"1","key":"3843_CR92","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.molcel.2015.04.027","volume":"59","author":"MH Jo","year":"2015","unstructured":"Jo MH, Shin S, Jung S-R, Kim E, Song J-J, Hohng S. Human argonaute 2 has diverse reaction pathways on target RNAs. Mol Cell. 2015;59(1):117\u201324.","journal-title":"Mol Cell"},{"issue":"6","key":"3843_CR93","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2174\/1389557515666150324123208","volume":"15","author":"B Simonson","year":"2015","unstructured":"Simonson B, Das S. MicroRNA therapeutics: the next magic bullet? Mini Rev Med Chem. 2015;15(6):467\u201374.","journal-title":"Mini Rev Med Chem"},{"issue":"7149","key":"3843_CR94","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nature05983","volume":"448","author":"JG Ruby","year":"2007","unstructured":"Ruby JG, Jan CH, Bartel DP. Intronic MicroRNA precursors that bypass drosha processing. Nature. 2007;448(7149):83\u20136.","journal-title":"Nature"},{"issue":"20","key":"3843_CR95","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1101\/gad.1705308","volume":"22","author":"JE Babiarz","year":"2008","unstructured":"Babiarz JE, Ruby JG, Wang Y, Bartel DP, Blelloch R. Mouse ES cells express endogenous shRNAs, siRNAs, and other Microprocessor-independent, Dicer-dependent small RNAs. Genes Dev. 2008;22(20):2773\u201385.","journal-title":"Genes Dev"},{"issue":"34","key":"3843_CR96","doi-asserted-by":"publisher","first-page":"15163","DOI":"10.1073\/pnas.1006432107","volume":"107","author":"J-S Yang","year":"2010","unstructured":"Yang J-S, Maurin T, Robine N, Rasmussen KD, Jeffrey KL, Chandwani R, et al. Conserved vertebrate mir-451 provides a platform for Dicer-independent, Ago2-mediated MicroRNA biogenesis. Proc Natl Acad Sci. 2010;107(34):15163\u20138.","journal-title":"Proc Natl Acad Sci"},{"issue":"5589","key":"3843_CR97","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1126\/science.1073827","volume":"297","author":"G Hutvagner","year":"2002","unstructured":"Hutvagner G, Zamore PD. A MicroRNA in a multiple-turnover RNAi enzyme complex. Science. 2002;297(5589):2056\u201360.","journal-title":"Science"},{"issue":"11","key":"3843_CR98","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1105\/tpc.016238","volume":"15","author":"MJ Aukerman","year":"2003","unstructured":"Aukerman MJ, Sakai H. Regulation of flowering time and floral organ identity by a MicroRNA and its APETALA2-like target genes. Plant Cell. 2003;15(11):2730\u201341.","journal-title":"Plant Cell"},{"issue":"11","key":"3843_CR99","doi-asserted-by":"publisher","first-page":"4034","DOI":"10.1073\/pnas.0510928103","volume":"103","author":"L Wu","year":"2006","unstructured":"Wu L, Fan J, Belasco JG. MicroRNAs direct rapid deadenylation of mRNA. Proc Natl Acad Sci. 2006;103(11):4034\u20139.","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"3843_CR100","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/wrna.121","volume":"3","author":"S Vasudevan","year":"2012","unstructured":"Vasudevan S. Posttranscriptional upregulation by MicroRNAs. WIREs RNA. 2012;3(3):311\u201330. https:\/\/doi.org\/10.1002\/wrna.121.","journal-title":"WIREs RNA"},{"key":"3843_CR101","doi-asserted-by":"publisher","first-page":"15004","DOI":"10.1038\/sigtrans.2015.4","volume":"1","author":"Y Peng","year":"2016","unstructured":"Peng Y, Croce CM. The role of MicroRNAs in human cancer. Signal Transduct Target Ther. 2016;1:15004. https:\/\/doi.org\/10.1038\/sigtrans.2015.4.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"3843_CR102","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"issue":"38","key":"3843_CR103","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1038\/s41388-023-02780-w","volume":"42","author":"G Pisignano","year":"2023","unstructured":"Pisignano G, Michael DC, Visal TH, Pirlog R, Ladomery M, Calin GA. Going circular: history, present, and future of circrnas in cancer. Oncogene. 2023;42(38):2783\u2013800. https:\/\/doi.org\/10.1038\/s41388-023-02780-w.","journal-title":"Oncogene"},{"key":"3843_CR104","doi-asserted-by":"publisher","unstructured":"Guria A, Sharma P, Natesan S, Pandi G. Circular RNAs\u2014The road less traveled. Front Mol Biosci. 2020;6. https:\/\/doi.org\/10.3389\/fmolb.2019.00146.","DOI":"10.3389\/fmolb.2019.00146"},{"key":"3843_CR105","doi-asserted-by":"publisher","unstructured":"Gu A, Jaijyan DK, Yang S, Zeng M, Pei S, Zhu H. Functions of circular RNA in human diseases and illnesses. Noncoding RNA. 2023;9(4). https:\/\/doi.org\/10.3390\/ncrna9040038.","DOI":"10.3390\/ncrna9040038"},{"issue":"3","key":"3843_CR106","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrm.2017.104","volume":"19","author":"JD Ransohoff","year":"2018","unstructured":"Ransohoff JD, Wei Y, Khavari PA. The functions and unique features of long intergenic non-coding RNA. Nat Rev Mol Cell Biol. 2018;19(3):143\u201357. https:\/\/doi.org\/10.1038\/nrm.2017.104.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"3843_CR107","doi-asserted-by":"publisher","first-page":"5785","DOI":"10.1007\/s12035-022-02941-0","volume":"59","author":"P Plewka","year":"2022","unstructured":"Plewka P, Raczynska KD. Long intergenic noncoding RNAs affect biological pathways underlying autoimmune and neurodegenerative disorders. Mol Neurobiol. 2022;59(9):5785\u2013808. https:\/\/doi.org\/10.1007\/s12035-022-02941-0.","journal-title":"Mol Neurobiol"},{"issue":"6","key":"3843_CR108","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41594-020-0446-0","volume":"27","author":"V Sartorelli","year":"2020","unstructured":"Sartorelli V, Lauberth SM. Enhancer RNAs are an important regulatory layer of the epigenome. Nat Struct Mol Biol. 2020;27(6):521\u20138. https:\/\/doi.org\/10.1038\/s41594-020-0446-0.","journal-title":"Nat Struct Mol Biol"},{"key":"3843_CR109","doi-asserted-by":"publisher","unstructured":"Yue Y, Lin X, Qiu X, Yang L, Wang R. The molecular roles and clinical implications of Non-Coding RNAs in gastric cancer. Front Cell Dev Biology. 2021;9. https:\/\/doi.org\/10.3389\/fcell.2021.802745.","DOI":"10.3389\/fcell.2021.802745"},{"issue":"1","key":"3843_CR110","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12943-020-01185-7","volume":"19","author":"L Wei","year":"2020","unstructured":"Wei L, Sun J, Zhang N, Zheng Y, Wang X, Lv L, et al. Noncoding RNAs in gastric cancer: implications for drug resistance. Mol Cancer. 2020;19(1):62. https:\/\/doi.org\/10.1186\/s12943-020-01185-7.","journal-title":"Mol Cancer"},{"issue":"24","key":"3843_CR111","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.3748\/wjg.v26.i24.3401","volume":"26","author":"Y Gao","year":"2020","unstructured":"Gao Y, Wang JW, Ren JY, Guo M, Guo CW, Ning SW, et al. Long noncoding RNAs in gastric cancer: from molecular dissection to clinical application. World J Gastroenterol. 2020;26(24):3401\u201312. https:\/\/doi.org\/10.3748\/wjg.v26.i24.3401.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"3843_CR112","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ncrna.2020.06.003","volume":"5","author":"S Ghafouri-Fard","year":"2020","unstructured":"Ghafouri-Fard S, Dashti S, Taheri M, Omrani MD. TINCR: an LncRNA with dual functions in the carcinogenesis process. Noncoding RNA Res. 2020;5(3):109\u201315. https:\/\/doi.org\/10.1016\/j.ncrna.2020.06.003.","journal-title":"Noncoding RNA Res"},{"issue":"6","key":"3843_CR113","doi-asserted-by":"publisher","first-page":"7246","DOI":"10.1002\/cam4.5446","volume":"12","author":"Q Xu","year":"2023","unstructured":"Xu Q, Yao Y, Ni H, Gu J, Wang X, Jiang L, et al. Hsa-circ-0052001 promotes gastric cancer cell proliferation and invasion via the MAPK pathway. Cancer Med. 2023;12(6):7246\u201357. https:\/\/doi.org\/10.1002\/cam4.5446.","journal-title":"Cancer Med"},{"issue":"7","key":"3843_CR114","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41419-023-05953-3","volume":"14","author":"H Kitajima","year":"2023","unstructured":"Kitajima H, Maruyama R, Niinuma T, Yamamoto E, Takasawa A, Takasawa K, et al. TM4SF1-AS1 inhibits apoptosis by promoting stress granule formation in cancer cells. Cell Death Dis. 2023;14(7):424. https:\/\/doi.org\/10.1038\/s41419-023-05953-3.","journal-title":"Cell Death Dis"},{"issue":"17","key":"3843_CR115","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1111\/j.1742-4658.2012.08694.x","volume":"279","author":"F Yang","year":"2012","unstructured":"Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J, et al. Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells. Febs J. 2012;279(17):3159\u201365. https:\/\/doi.org\/10.1111\/j.1742-4658.2012.08694.x.","journal-title":"Febs J"},{"key":"3843_CR116","doi-asserted-by":"publisher","unstructured":"Zhang W, Zhou K, Zhang X, Wu C, Deng D, Yao Z. Roles of the H19\/microRNA\u2013675 axis in the proliferation and epithelial\u2013mesenchymal transition of human cutaneous squamous cell carcinoma cells. Oncol Rep. 2021;45(4). https:\/\/doi.org\/10.3892\/or.2021.7990.","DOI":"10.3892\/or.2021.7990"},{"issue":"3","key":"3843_CR117","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3727\/096504015x14496932933575","volume":"23","author":"G Liu","year":"2016","unstructured":"Liu G, Xiang T, Wu QF, Wang WX, Long noncoding RNA H19-Derived miR-675 enhances proliferation and invasion via RUNX1 in gastric cancer cells. Oncol Res. 2016;23(3):99\u2013107. https:\/\/doi.org\/10.3727\/096504015x14496932933575.","journal-title":"Oncol Res"},{"issue":"6","key":"3843_CR118","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1159\/000480028","volume":"42","author":"J Yan","year":"2017","unstructured":"Yan J, Zhang Y, She Q, Li X, Peng L, Wang X, et al. Long noncoding RNA H19\/miR-675 axis promotes gastric cancer via FADD\/Caspase 8\/Caspase 3 signaling pathway. Cell Physiol Biochem. 2017;42(6):2364\u201376. https:\/\/doi.org\/10.1159\/000480028.","journal-title":"Cell Physiol Biochem"},{"issue":"3","key":"3843_CR119","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.3892\/ol.2018.9052","volume":"16","author":"W Yang","year":"2018","unstructured":"Yang W, Redpath RE, Zhang C, Ning N. Long non-coding RNA H19 promotes the migration and invasion of colon cancer cells via MAPK signaling pathway. Oncol Lett. 2018;16(3):3365\u201372. https:\/\/doi.org\/10.3892\/ol.2018.9052.","journal-title":"Oncol Lett"},{"issue":"8","key":"3843_CR120","first-page":"3522","volume":"8","author":"P Li","year":"2016","unstructured":"Li P, Xue WJ, Feng Y, Mao QS. Long non-coding RNA CASC2 suppresses the proliferation of gastric cancer cells by regulating the MAPK signaling pathway. Am J Transl Res. 2016;8(8):3522\u20139.","journal-title":"Am J Transl Res"},{"key":"3843_CR121","doi-asserted-by":"publisher","first-page":"116649","DOI":"10.1016\/j.lfs.2019.116649","volume":"232","author":"Y Li","year":"2019","unstructured":"Li Y, Jiang L, Lv S, Xu H, Fan Z, He Y, et al. E2F6-mediated LncRNA CASC2 down-regulation predicts poor prognosis and promotes progression in gastric carcinoma. Life Sci. 2019;232:116649. https:\/\/doi.org\/10.1016\/j.lfs.2019.116649.","journal-title":"Life Sci"},{"issue":"2","key":"3843_CR122","doi-asserted-by":"publisher","first-page":"588","DOI":"10.26355\/eurrev_201901_16871","volume":"23","author":"JF Li","year":"2019","unstructured":"Li JF, Li WH, Xue LL, Zhang Y. Long non-coding RNA PICART1 inhibits cell proliferation by regulating the PI3K\/AKT and MAPK\/ERK signaling pathways in gastric cancer. Eur Rev Med Pharmacol Sci. 2019;23(2):588\u201397. https:\/\/doi.org\/10.26355\/eurrev_201901_16871.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"3843_CR123","doi-asserted-by":"publisher","first-page":"18312","DOI":"10.1038\/s41598-022-21492-x","volume":"12","author":"S Gupta","year":"2022","unstructured":"Gupta S, Panda PK, Luo W, Hashimoto RF, Ahuja R. Network analysis reveals that the tumor suppressor LncRNA GAS5 acts as a double-edged sword in response to DNA damage in gastric cancer. Sci Rep. 2022;12(1):18312. https:\/\/doi.org\/10.1038\/s41598-022-21492-x.","journal-title":"Sci Rep"},{"issue":"1","key":"3843_CR124","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12943-021-01358-y","volume":"20","author":"T Jiang","year":"2021","unstructured":"Jiang T, Xia Y, Lv J, Li B, Li Y, Wang S, et al. A novel protein encoded by circMAPK1 inhibits progression of gastric cancer by suppressing activation of MAPK signaling. Mol Cancer. 2021;20(1):66. https:\/\/doi.org\/10.1186\/s12943-021-01358-y.","journal-title":"Mol Cancer"},{"key":"3843_CR125","doi-asserted-by":"publisher","first-page":"8589","DOI":"10.2147\/cmar.S186002","volume":"11","author":"H Zhang","year":"2019","unstructured":"Zhang H, Zhang Z, Wang D. Epigenetic regulation of IncRNA KCNKI5-ASI in gastric cancer. Cancer Manag Res. 2019;11:8589\u2013602. https:\/\/doi.org\/10.2147\/cmar.S186002.","journal-title":"Cancer Manag Res"},{"issue":"12","key":"3843_CR126","first-page":"8471","volume":"7","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Ma M, Liu W, Ding W, Yu H. Enhanced expression of long noncoding RNA CARLo-5 is associated with the development of gastric cancer. Int J Clin Exp Pathol. 2014;7(12):8471\u20139.","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"3843_CR127","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.ejps.2016.10.024","volume":"21","author":"JN Liu","year":"2017","unstructured":"Liu JN, Shangguan YM. Long non-coding RNA CARLo-5 upregulation associates with poor prognosis in patients suffering gastric cancer. Eur Rev Med Pharmacol Sci. 2017;21(3):530\u20134.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"11","key":"3843_CR128","doi-asserted-by":"publisher","first-page":"4173","DOI":"10.1073\/pnas.1400350111","volume":"111","author":"T Kim","year":"2014","unstructured":"Kim T, Cui R, Jeon YJ, Lee JH, Lee JH, Sim H, et al. Long-range interaction and correlation between MYC enhancer and oncogenic long noncoding RNA CARLo-5. Proc Natl Acad Sci U S A. 2014;111(11):4173\u20138. https:\/\/doi.org\/10.1073\/pnas.1400350111.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3843_CR129","doi-asserted-by":"crossref","unstructured":"Dou C, Sun L, Jin X, Han M, Zhang B, Jiang X et al. Long non-coding RNA CARLo-5 promotes tumor progression in hepatocellular carcinoma via suppressing miR-200b expression. Oncotarget. 2017;8(41).","DOI":"10.18632\/oncotarget.19597"},{"issue":"3","key":"3843_CR130","doi-asserted-by":"publisher","first-page":"6509","DOI":"10.1080\/21655979.2022.2034585","volume":"13","author":"D Li","year":"2022","unstructured":"Li D, Li Q. MicroRNA-200b-3p restrains gastric cancer cell proliferation, migration, and invasion via C-X-C motif chemokine ligand 12\/CXC chemokine receptor 7 axis. Bioengineered. 2022;13(3):6509\u201320. https:\/\/doi.org\/10.1080\/21655979.2022.2034585.","journal-title":"Bioengineered"},{"issue":"1","key":"3843_CR131","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41388-021-02067-y","volume":"41","author":"L Yu","year":"2022","unstructured":"Yu L, Cao C, Li X, Zhang M, Gu Q, Gao H, et al. Complete loss of miR-200 family induces EMT associated cellular senescence in gastric cancer. Oncogene. 2022;41(1):26\u201336. https:\/\/doi.org\/10.1038\/s41388-021-02067-y.","journal-title":"Oncogene"},{"key":"3843_CR132","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.2147\/ott.S168819","volume":"11","author":"L Wu","year":"2018","unstructured":"Wu L, Yin JH, Guan YY, Liu HL, Shen HL, Wang XJ, et al. A long noncoding RNA MAP3K1-2 promotes proliferation and invasion in gastric cancer. Onco Targets Ther. 2018;11:4631\u20139. https:\/\/doi.org\/10.2147\/ott.S168819.","journal-title":"Onco Targets Ther"},{"issue":"7","key":"3843_CR133","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.26355\/eurrev_202004_20828","volume":"24","author":"GR Zhou","year":"2020","unstructured":"Zhou GR, Huang DP, Sun ZF, Zhang XF. Long non-coding RNA BCAR4 accelerates cell proliferation and suppresses cell apoptosis in gastric cancer via regulating MAPK\/ERK signaling. Eur Rev Med Pharmacol Sci. 2020;24(7):3657\u201364. https:\/\/doi.org\/10.26355\/eurrev_202004_20828.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"40","key":"3843_CR134","doi-asserted-by":"publisher","first-page":"42813","DOI":"10.18632\/oncotarget.5970","volume":"6","author":"J Ji","year":"2015","unstructured":"Ji J, Tang J, Deng L, Xie Y, Jiang R, Li G, et al. LINC00152 promotes proliferation in hepatocellular carcinoma by targeting EpCAM via the mTOR signaling pathway. Oncotarget. 2015;6(40):42813\u201324. https:\/\/doi.org\/10.18632\/oncotarget.5970.","journal-title":"Oncotarget"},{"issue":"6","key":"3843_CR135","doi-asserted-by":"publisher","first-page":"5441","DOI":"10.1007\/s13277-014-1709-3","volume":"35","author":"Q Pang","year":"2014","unstructured":"Pang Q, Ge J, Shao Y, Sun W, Song H, Xia T, et al. Increased expression of long intergenic non-coding RNA LINC00152 in gastric cancer and its clinical significance. Tumour Biol. 2014;35(6):5441\u20137. https:\/\/doi.org\/10.1007\/s13277-014-1709-3.","journal-title":"Tumour Biol"},{"issue":"10","key":"3843_CR136","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.26355\/eurrev_201805_15067","volume":"22","author":"XL Hu","year":"2018","unstructured":"Hu XL, Wang J, He W, Zhao P, Wu WQ. Down-regulation of LncRNA Linc00152 suppressed cell viability, invasion, migration, and epithelial to mesenchymal transition, and reversed chemo-resistance in breast cancer cells. Eur Rev Med Pharmacol Sci. 2018;22(10):3074\u201384. https:\/\/doi.org\/10.26355\/eurrev_201805_15067.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3843_CR137","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.2147\/ott.S217452","volume":"13","author":"Y Shi","year":"2020","unstructured":"Shi Y, Sun H. Down-regulation of LncRNA LINC00152 suppresses gastric cancer cell migration and invasion through Inhibition of the ERK\/MAPK signaling pathway. Onco Targets Ther. 2020;13:2115\u201324. https:\/\/doi.org\/10.2147\/ott.S217452.","journal-title":"Onco Targets Ther"},{"key":"3843_CR138","doi-asserted-by":"publisher","first-page":"e8050","DOI":"10.7717\/peerj.8050","volume":"8","author":"Q Chen","year":"2020","unstructured":"Chen Q, Huang X, Dong X, Wu J, Teng F, Xu H. Long non-coding RNA ERICH3-AS1 is an unfavorable prognostic factor for gastric cancer. PeerJ. 2020;8:e8050. https:\/\/doi.org\/10.7717\/peerj.8050.","journal-title":"PeerJ"},{"issue":"8","key":"3843_CR139","doi-asserted-by":"publisher","first-page":"3875","DOI":"10.1111\/jcmm.13661","volume":"22","author":"D Li","year":"2018","unstructured":"Li D, Yang M, Liao A, Zeng B, Liu D, Yao Y, et al. Linc00483 as CeRNA regulates proliferation and apoptosis through activating MAPKs in gastric cancer. J Cell Mol Med. 2018;22(8):3875\u201386. https:\/\/doi.org\/10.1111\/jcmm.13661.","journal-title":"J Cell Mol Med"},{"issue":"10","key":"3843_CR140","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1158\/1078-0432.Ccr-18-2804","volume":"25","author":"X Wang","year":"2019","unstructured":"Wang X, Liang Q, Zhang L, Gou H, Li Z, Chen H, et al. C8orf76 promotes gastric tumorigenicity and metastasis by directly inducing LncRNA DUSP5P1 and associates with patient outcomes. Clin Cancer Res. 2019;25(10):3128\u201340. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-18-2804.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3843_CR141","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41389-022-00441-3","volume":"11","author":"X Wang","year":"2022","unstructured":"Wang X, Zhang L, Liang Q, Wong CC, Chen H, Gou H, et al. DUSP5P1 promotes gastric cancer metastasis and platinum drug resistance. Oncogenesis. 2022;11(1):66. https:\/\/doi.org\/10.1038\/s41389-022-00441-3.","journal-title":"Oncogenesis"},{"issue":"1","key":"3843_CR142","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1038\/s41467-018-04006-0","volume":"9","author":"Z Li","year":"2018","unstructured":"Li Z, Zhang J, Liu X, Li S, Wang Q, Di C, et al. The LINC01138 drives malignancies via activating arginine methyltransferase 5 in hepatocellular carcinoma. Nat Commun. 2018;9(1):1572. https:\/\/doi.org\/10.1038\/s41467-018-04006-0.","journal-title":"Nat Commun"},{"issue":"37","key":"3843_CR143","doi-asserted-by":"publisher","first-page":"60503","DOI":"10.18632\/oncotarget.11391","volume":"7","author":"X Wan","year":"2016","unstructured":"Wan X, Huang W, Yang S, Zhang Y, Pu H, Fu F, et al. Identification of androgen-responsive LncRNAs as diagnostic and prognostic markers for prostate cancer. Oncotarget. 2016;7(37):60503\u201318. https:\/\/doi.org\/10.18632\/oncotarget.11391.","journal-title":"Oncotarget"},{"key":"3843_CR144","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.12659\/msm.914248","volume":"25","author":"GX Dou","year":"2019","unstructured":"Dou GX, Zhang JN, Wang P, Wang JL, Sun GB. Long intergenic Non-Protein-Coding RNA 01138 accelerates tumor growth and invasion in gastric cancer by regulating miR-1273e. Med Sci Monit. 2019;25:2141\u201350. https:\/\/doi.org\/10.12659\/msm.914248.","journal-title":"Med Sci Monit"},{"issue":"27","key":"3843_CR145","doi-asserted-by":"publisher","first-page":"23342","DOI":"10.18632\/oncotarget.4344","volume":"6","author":"TH Wang","year":"2015","unstructured":"Wang TH, Lin YS, Chen Y, Yeh CT, Huang YL, Hsieh TH, et al. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition. Oncotarget. 2015;6(27):23342\u201357. https:\/\/doi.org\/10.18632\/oncotarget.4344.","journal-title":"Oncotarget"},{"issue":"20","key":"3843_CR146","doi-asserted-by":"publisher","first-page":"8852","DOI":"10.26355\/eurrev_201910_19280","volume":"23","author":"CX Qu","year":"2019","unstructured":"Qu CX, Shi XC, Bi H, Zhai LQ, Yang Q. LncRNA AOC4P affects biological behavior of gastric cancer cells through MAPK signaling pathway. Eur Rev Med Pharmacol Sci. 2019;23(20):8852\u201360. https:\/\/doi.org\/10.26355\/eurrev_201910_19280.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"5","key":"3843_CR147","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/carcin\/bgac018","volume":"43","author":"Z Gao","year":"2022","unstructured":"Gao Z, Long Y, Wu Y, Pu Y, Xue F. LncRNA LINC02253 activates KRT18\/MAPK\/ERK pathway by mediating N6-methyladenosine modification of KRT18 mRNA in gastric cancer. Carcinogenesis. 2022;43(5):419\u201329. https:\/\/doi.org\/10.1093\/carcin\/bgac018.","journal-title":"Carcinogenesis"},{"key":"3843_CR148","doi-asserted-by":"publisher","unstructured":"Zhang J, Hu S, Li Y. KRT18 is correlated with the malignant status and acts as an oncogene in colorectal cancer. Biosci Rep. 2019;39(8). https:\/\/doi.org\/10.1042\/bsr20190884.","DOI":"10.1042\/bsr20190884"},{"issue":"1","key":"3843_CR149","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/1440-1681.13401","volume":"48","author":"PB Wang","year":"2021","unstructured":"Wang PB, Chen Y, Ding GR, Du HW, Fan HY. Keratin 18 induces proliferation, migration, and invasion in gastric cancer via the MAPK signalling pathway. Clin Exp Pharmacol Physiol. 2021;48(1):147\u201356. https:\/\/doi.org\/10.1111\/1440-1681.13401.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"3843_CR150","doi-asserted-by":"publisher","first-page":"1448502","DOI":"10.3389\/fonc.2024.1448502","volume":"14","author":"X Jiang","year":"2024","unstructured":"Jiang X, Wu X, Lu M, Fan W, Song J, Song F. Long non-coding RNA FAM87A is associated with overall survival and promotes cell migration and invasion in gastric cancer. Front Oncol. 2024;14:1448502. https:\/\/doi.org\/10.3389\/fonc.2024.1448502.","journal-title":"Front Oncol"},{"issue":"3","key":"3843_CR151","doi-asserted-by":"publisher","first-page":"e70187","DOI":"10.1002\/jbt.70187","volume":"39","author":"Y Hu","year":"2025","unstructured":"Hu Y, Zhang Y, Ding M, Xu R. HOXA10-AS enhances gastric cancer cell Proliferation, Migration, and invasion via the p38 MAPK\/STAT3 signaling pathway. J Biochem Mol Toxicol. 2025;39(3):e70187. https:\/\/doi.org\/10.1002\/jbt.70187.","journal-title":"J Biochem Mol Toxicol"},{"issue":"23","key":"3843_CR152","doi-asserted-by":"publisher","first-page":"10902","DOI":"10.18632\/aging.102493","volume":"11","author":"R Zhang","year":"2019","unstructured":"Zhang R, Liu Y, Liu H, Chen W, Fan HN, Zhang J, et al. The long non-coding RNA SNHG12 promotes gastric cancer by activating the phosphatidylinositol 3-kinase\/AKT pathway. Aging. 2019;11(23):10902\u201322. https:\/\/doi.org\/10.18632\/aging.102493.","journal-title":"Aging"},{"issue":"7","key":"3843_CR153","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.7150\/ijbs.58921","volume":"17","author":"T Zhang","year":"2021","unstructured":"Zhang T, Beeharry MK, Wang Z, Zhu Z, Li J, Li C. YY1-modulated long non-coding RNA SNHG12 promotes gastric cancer metastasis by activating the miR-218-5p\/YWHAZ axis. Int J Biol Sci. 2021;17(7):1629\u201343. https:\/\/doi.org\/10.7150\/ijbs.58921.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"3843_CR154","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41420-022-00925-6","volume":"8","author":"F Zhang","year":"2022","unstructured":"Zhang F, Guo C, Cao X, Yan Y, Zhang J, Lv S. Gastric cancer cell-derived extracellular vesicles elevate E2F7 expression and activate the MAPK\/ERK signaling to promote peritoneal metastasis through the delivery of SNHG12. Cell Death Discov. 2022;8(1):164. https:\/\/doi.org\/10.1038\/s41420-022-00925-6.","journal-title":"Cell Death Discov"},{"issue":"11","key":"3843_CR155","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/s41419-022-05436-x","volume":"13","author":"Q He","year":"2022","unstructured":"He Q, Yang C, Xiang Z, Huang G, Wu H, Chen T, et al. LINC00924-induced fatty acid metabolic reprogramming facilitates gastric cancer peritoneal metastasis via hnRNPC-regulated alternative splicing of Mnk2. Cell Death Dis. 2022;13(11):987. https:\/\/doi.org\/10.1038\/s41419-022-05436-x.","journal-title":"Cell Death Dis"},{"key":"3843_CR156","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3389\/fonc.2020.00633","volume":"10","author":"YY Sun","year":"2020","unstructured":"Sun YY, Zhang H, Ma RR, Zhang GH, Tian YR, Liu L, et al. Long Non-coding RNA AK025387 promotes cell migration and invasion of gastric cancer. Front Oncol. 2020;10:633. https:\/\/doi.org\/10.3389\/fonc.2020.00633.","journal-title":"Front Oncol"},{"key":"3843_CR157","doi-asserted-by":"publisher","unstructured":"Jiang F, Liu G, Chen X, Li Q, Fang F, Shen X. Hsa_circ_0044301 Regulates Gastric Cancer Cell\u2019s Proliferation, Migration, and Invasion by Modulating the Hsa-miR-188-5p\/DAXX Axis and MAPK Pathway. Cancers (Basel). 2022;14(17). https:\/\/doi.org\/10.3390\/cancers14174183.","DOI":"10.3390\/cancers14174183"},{"issue":"4","key":"3843_CR158","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1158\/0008-5472.Can-22-1923","volume":"83","author":"Y Shen","year":"2023","unstructured":"Shen Y, Zhang N, Chai J, Wang T, Ma C, Han L, et al. CircPDIA4 induces gastric cancer progression by promoting ERK1\/2 activation and enhancing biogenesis of oncogenic circrnas. Cancer Res. 2023;83(4):538\u201352. https:\/\/doi.org\/10.1158\/0008-5472.Can-22-1923.","journal-title":"Cancer Res"},{"key":"3843_CR159","doi-asserted-by":"publisher","first-page":"119499","DOI":"10.1016\/j.lfs.2021.119499","volume":"278","author":"ER Asl","year":"2021","unstructured":"Asl ER, Amini M, Najafi S, Mansoori B, Mokhtarzadeh A, Mohammadi A, et al. Interplay between MAPK\/ERK signaling pathway and micrornas: A crucial mechanism regulating cancer cell metabolism and tumor progression. Life Sci. 2021;278:119499. https:\/\/doi.org\/10.1016\/j.lfs.2021.119499.","journal-title":"Life Sci"},{"issue":"12","key":"3843_CR160","first-page":"2840","volume":"21","author":"B Li","year":"2017","unstructured":"Li B, Liu YH, Sun AG, Huan LC, Li HD, Liu DM. MiR-130b functions as a tumor promoter in glioma via regulation of ERK\/MAPK pathway. Eur Rev Med Pharmacol Sci. 2017;21(12):2840\u20136.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1\u20132","key":"3843_CR161","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s11010-013-1693-8","volume":"381","author":"F Liu","year":"2013","unstructured":"Liu F, Zheng S, Liu T, Liu Q, Liang M, Li X, et al. MicroRNA-21 promotes the proliferation and inhibits apoptosis in Eca109 via activating ERK1\/2\/MAPK pathway. Mol Cell Biochem. 2013;381(1\u20132):115\u201325. https:\/\/doi.org\/10.1007\/s11010-013-1693-8.","journal-title":"Mol Cell Biochem"},{"issue":"14","key":"3843_CR162","doi-asserted-by":"publisher","first-page":"22443","DOI":"10.18632\/oncotarget.12338","volume":"8","author":"JY Ho","year":"2017","unstructured":"Ho JY, Hsu RJ, Liu JM, Chen SC, Liao GS, Gao HW, et al. MicroRNA-382-5p aggravates breast cancer progression by regulating the RERG\/Ras\/ERK signaling axis. Oncotarget. 2017;8(14):22443\u201359. https:\/\/doi.org\/10.18632\/oncotarget.12338.","journal-title":"Oncotarget"},{"issue":"1\u20132","key":"3843_CR163","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s11010-015-2630-9","volume":"412","author":"Y Lu","year":"2016","unstructured":"Lu Y, Yang H, Yuan L, Liu G, Zhang C, Hong M, et al. Overexpression of miR-335 confers cell proliferation and tumour growth to colorectal carcinoma cells. Mol Cell Biochem. 2016;412(1\u20132):235\u201345. https:\/\/doi.org\/10.1007\/s11010-015-2630-9.","journal-title":"Mol Cell Biochem"},{"issue":"13","key":"3843_CR164","doi-asserted-by":"publisher","first-page":"9508","DOI":"10.1074\/jbc.M112.367763","volume":"288","author":"D Sun","year":"2013","unstructured":"Sun D, Yu F, Ma Y, Zhao R, Chen X, Zhu J, et al. MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1). J Biol Chem. 2013;288(13):9508\u201318. https:\/\/doi.org\/10.1074\/jbc.M112.367763.","journal-title":"J Biol Chem"},{"issue":"1","key":"3843_CR165","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12935-015-0192-2","volume":"15","author":"Z Wang","year":"2015","unstructured":"Wang Z, Ma B, Ji X, Deng Y, Zhang T, Zhang X, et al. MicroRNA-378-5p suppresses cell proliferation and induces apoptosis in colorectal cancer cells by targeting BRAF. Cancer Cell Int. 2015;15(1):40. https:\/\/doi.org\/10.1186\/s12935-015-0192-2.","journal-title":"Cancer Cell Int"},{"key":"3843_CR166","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.2147\/ott.S65548","volume":"7","author":"A Fesler","year":"2014","unstructured":"Fesler A, Zhai H, Ju J. miR-129 as a novel therapeutic target and biomarker in Gastrointestinal cancer. Onco Targets Ther. 2014;7:1481\u20135. https:\/\/doi.org\/10.2147\/ott.S65548.","journal-title":"Onco Targets Ther"},{"issue":"2","key":"3843_CR167","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s12094-016-1516-y","volume":"19","author":"CY Li","year":"2017","unstructured":"Li CY, Liang GY, Yao WZ, Sui J, Shen X, Zhang YQ, et al. Identification and functional characterization of MicroRNAs reveal a potential role in gastric cancer progression. Clin Transl Oncol. 2017;19(2):162\u201372. https:\/\/doi.org\/10.1007\/s12094-016-1516-y.","journal-title":"Clin Transl Oncol"},{"key":"3843_CR168","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3389\/fphar.2018.00502","volume":"9","author":"D Chen","year":"2018","unstructured":"Chen D, Wang H, Chen J, Li Z, Li S, Hu Z, et al. MicroRNA-129-5p regulates Glycolysis and cell proliferation by targeting the glucose transporter SLC2A3 in gastric cancer cells. Front Pharmacol. 2018;9:502. https:\/\/doi.org\/10.3389\/fphar.2018.00502.","journal-title":"Front Pharmacol"},{"issue":"3","key":"3843_CR169","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/jcp.21885","volume":"221","author":"S Rodr\u00edguez-Enr\u00edquez","year":"2009","unstructured":"Rodr\u00edguez-Enr\u00edquez S, Mar\u00edn\u2010Hern\u00e1ndez A, Gallardo\u2010P\u00e9rez JC, Moreno\u2010S\u00e1nchez R. Kinetics of transport and phosphorylation of glucose in cancer cells. J Cell Physiol. 2009;221(3):552\u20139.","journal-title":"J Cell Physiol"},{"issue":"4A","key":"3843_CR170","first-page":"2747","volume":"17","author":"M Younes","year":"1997","unstructured":"Younes M, Lechago LV, Somoano JR, Mosharaf M, Lechago J. Immunohistochemical detection of Glut3 in human tumors and normal tissues. Anticancer Res. 1997;17(4A):2747\u201350.","journal-title":"Anticancer Res"},{"issue":"2","key":"3843_CR171","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nrc2981","volume":"11","author":"RA Cairns","year":"2011","unstructured":"Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer. 2011;11(2):85\u201395.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"3843_CR172","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.metabol.2015.10.007","volume":"65","author":"CC Barron","year":"2016","unstructured":"Barron CC, Bilan PJ, Tsakiridis T, Tsiani E. Facilitative glucose transporters: implications for cancer detection, prognosis and treatment. Metabolism. 2016;65(2):124\u201339.","journal-title":"Metabolism"},{"issue":"3","key":"3843_CR173","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41419-018-0343-1","volume":"9","author":"A Zeng","year":"2018","unstructured":"Zeng A, Yin J, Li Y, Li R, Wang Z, Zhou X, et al. miR-129-5p targets Wnt5a to block PKC\/ERK\/NF-\u03baB and JNK pathways in glioblastoma. Cell Death Dis. 2018;9(3):394. https:\/\/doi.org\/10.1038\/s41419-018-0343-1.","journal-title":"Cell Death Dis"},{"issue":"11","key":"3843_CR174","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/s41419-019-1923-4","volume":"10","author":"Z Li","year":"2019","unstructured":"Li Z, Lu J, Zeng G, Pang J, Zheng X, Feng J, et al. MiR-129-5p inhibits liver cancer growth by targeting calcium calmodulin-dependent protein kinase IV (CAMK4). Cell Death Dis. 2019;10(11):789. https:\/\/doi.org\/10.1038\/s41419-019-1923-4.","journal-title":"Cell Death Dis"},{"issue":"12","key":"3843_CR175","doi-asserted-by":"publisher","first-page":"152641","DOI":"10.1016\/j.prp.2019.152641","volume":"215","author":"Y Liu","year":"2019","unstructured":"Liu Y, Liang G, Wang H, Liu Z. MicroRNA-129-5p suppresses proliferation, migration and invasion of retinoblastoma cells through PI3K\/AKT signaling pathway by targeting PAX6. Pathol Res Pract. 2019;215(12):152641. https:\/\/doi.org\/10.1016\/j.prp.2019.152641.","journal-title":"Pathol Res Pract"},{"key":"3843_CR176","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.14171","author":"Y Dehuo","year":"2025","unstructured":"Dehuo Y, Ying W, Lin C. Regulation of the MAPK\/ERK pathway by miRNA-27b in gastric cancer: diagnostic implications and therapeutic potential of Aloin. Asia Pac J Clin Oncol. 2025. https:\/\/doi.org\/10.1111\/ajco.14171.","journal-title":"Asia Pac J Clin Oncol"},{"issue":"1","key":"3843_CR177","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s12672-022-00589-9","volume":"13","author":"R Zhang","year":"2022","unstructured":"Zhang R, Huang T, Li J, Zhou H, Wang X. Effect of miR-27b on the proliferation and apoptosis of diffuse large b-cell lymphoma cells by targeting the regulation of MET\/PI3K\/AKT pathway. Discover Oncol. 2022;13(1):137. https:\/\/doi.org\/10.1007\/s12672-022-00589-9.","journal-title":"Discover Oncol"},{"issue":"2","key":"3843_CR178","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41419-017-0211-4","volume":"9","author":"D Chen","year":"2018","unstructured":"Chen D, Si W, Shen J, Du C, Lou W, Bao C, et al. miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting CBLB\/GRB2 in breast cancer cells. Cell Death Dis. 2018;9(2):188. https:\/\/doi.org\/10.1038\/s41419-017-0211-4.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3843_CR179","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1186\/s12967-024-05998-8","volume":"22","author":"W Yuan","year":"2024","unstructured":"Yuan W, Shi Y, Dai S, Deng M, Zhu K, Xu Y, et al. The role of MAPK pathway in gastric cancer: unveiling molecular crosstalk and therapeutic prospects. J Transl Med. 2024;22(1):1142. https:\/\/doi.org\/10.1186\/s12967-024-05998-8.","journal-title":"J Transl Med"},{"issue":"3","key":"3843_CR180","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3892\/ol.2021.12921","volume":"22","author":"J Zhang","year":"2021","unstructured":"Zhang J, Hu C, Hu D, Fan Z. MicroRNA-1298-5p inhibits the tumorigenesis of breast cancer by targeting E2F1. Oncol Lett. 2021;22(3):660. https:\/\/doi.org\/10.3892\/ol.2021.12921.","journal-title":"Oncol Lett"},{"issue":"1","key":"3843_CR181","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13000-019-0911-4","volume":"14","author":"Z Du","year":"2019","unstructured":"Du Z, Wu J, Wang J, Liang Y, Zhang S, Shang Z, et al. MicroRNA-1298 is downregulated in non-small cell lung cancer and suppresses tumor progression in tumor cells. Diagn Pathol. 2019;14(1):132. https:\/\/doi.org\/10.1186\/s13000-019-0911-4.","journal-title":"Diagn Pathol"},{"issue":"5","key":"3843_CR182","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41419-022-04872-z","volume":"13","author":"Y Qi","year":"2022","unstructured":"Qi Y, Jin C, Qiu W, Zhao R, Wang S, Li B, et al. The dual role of glioma Exosomal micrornas: glioma eliminates tumor suppressor miR-1298-5p via exosomes to promote immunosuppressive effects of MDSCs. Cell Death Dis. 2022;13(5):426. https:\/\/doi.org\/10.1038\/s41419-022-04872-z.","journal-title":"Cell Death Dis"},{"issue":"2","key":"3843_CR183","first-page":"3115","volume":"17","author":"L Fan","year":"2018","unstructured":"Fan L, Tan B, Li Y, Zhao Q, Yuan H, Liu Y, et al. Upregulation of miR\u2013185 promotes apoptosis of the human gastric cancer cell line MGC803. Mol Med Rep. 2018;17(2):3115\u201322.","journal-title":"Mol Med Rep"},{"issue":"5","key":"3843_CR184","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.21037\/jgo-21-599","volume":"12","author":"Y Wang","year":"2021","unstructured":"Wang Y, Zhang J, Liu M, Zhang S, Wang W, Cheng S. Clinical values and potential pathways of miR-183-5p in gastric cancer: a study based on integrational bioinformatics analysis. J Gastrointest Oncol. 2021;12(5):2123\u201331. https:\/\/doi.org\/10.21037\/jgo-21-599.","journal-title":"J Gastrointest Oncol"},{"issue":"3","key":"3843_CR185","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.ymthe.2019.01.016","volume":"27","author":"Z Zheng","year":"2019","unstructured":"Zheng Z, Zheng X, Zhu Y, Gu X, Gu W, Xie X, et al. miR-183-5p inhibits occurrence and progression of acute myeloid leukemia via targeting erbin. Mol Ther. 2019;27(3):542\u201358. https:\/\/doi.org\/10.1016\/j.ymthe.2019.01.016.","journal-title":"Mol Ther"},{"issue":"1","key":"3843_CR186","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12894-023-01286-7","volume":"23","author":"Y Feng","year":"2023","unstructured":"Feng Y, Wang K, Qin M, Zhuang Q, Chen Z. MiR-183-5p promotes migration and invasion of prostate cancer by targeting TET1. BMC Urol. 2023;23(1):116. https:\/\/doi.org\/10.1186\/s12894-023-01286-7.","journal-title":"BMC Urol"},{"issue":"2","key":"3843_CR187","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41418-021-00864-2","volume":"29","author":"M Kudo","year":"2022","unstructured":"Kudo M, Zalles N, Distefano R, Nigita G, Veneziano D, Gasparini P, et al. Synergistic apoptotic effect of miR-183-5p and Polo-Like kinase 1 inhibitor NMS-P937 in breast cancer cells. Cell Death Differ. 2022;29(2):407\u201319. https:\/\/doi.org\/10.1038\/s41418-021-00864-2.","journal-title":"Cell Death Differ"},{"issue":"4","key":"3843_CR188","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1159\/000490839","volume":"47","author":"Y He","year":"2018","unstructured":"He Y, Ge Y, Jiang M, Zhou J, Luo D, Fan H, et al. MiR-592 promotes gastric cancer Proliferation, Migration, and invasion through the PI3K\/AKT and MAPK\/ERK signaling pathways by targeting Spry2. Cell Physiol Biochem. 2018;47(4):1465\u201381. https:\/\/doi.org\/10.1159\/000490839.","journal-title":"Cell Physiol Biochem"},{"issue":"11","key":"3843_CR189","doi-asserted-by":"publisher","first-page":"5258","DOI":"10.1016\/j.bbagen.2013.07.028","volume":"1830","author":"Q He","year":"2013","unstructured":"He Q, Zhou X, Li S, Jin Y, Chen Z, Chen D, et al. MicroRNA-181a suppresses salivary adenoid cystic carcinoma metastasis by targeting MAPK\u2013Snai2 pathway. Biochimica et biophysica acta (BBA) -. Gen Subj. 2013;1830(11):5258\u201366. https:\/\/doi.org\/10.1016\/j.bbagen.2013.07.028.","journal-title":"Gen Subj"},{"issue":"5","key":"3843_CR190","first-page":"4481","volume":"8","author":"ZJ Wei","year":"2015","unstructured":"Wei ZJ, Tao ML, Zhang W, Han GD, Zhu ZC, Miao ZG, et al. Up-regulation of microRNA-302a inhibited the proliferation and invasion of colorectal cancer cells by regulation of the MAPK and PI3K\/Akt signaling pathways. Int J Clin Exp Pathol. 2015;8(5):4481\u201391.","journal-title":"Int J Clin Exp Pathol"},{"issue":"2","key":"3843_CR191","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s13277-014-2766-3","volume":"36","author":"J Chai","year":"2015","unstructured":"Chai J, Wang S, Han D, Dong W, Xie C, Guo H. MicroRNA-455 inhibits proliferation and invasion of colorectal cancer by targeting RAF proto-oncogene serine\/threonine-protein kinase. Tumour Biol. 2015;36(2):1313\u201321. https:\/\/doi.org\/10.1007\/s13277-014-2766-3.","journal-title":"Tumour Biol"},{"issue":"2","key":"3843_CR192","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ol.2021.12428","volume":"21","author":"Z Wang","year":"2021","unstructured":"Wang Z, Liu Y. MicroRNA\u2013633 enhances melanoma cell proliferation and migration by suppressing KAI1. Oncol Lett. 2021;21(2):1.","journal-title":"Oncol Lett"},{"key":"3843_CR193","doi-asserted-by":"publisher","first-page":"154701","DOI":"10.1016\/j.prp.2023.154701","volume":"248","author":"J Gupta","year":"2023","unstructured":"Gupta J, Suliman M, Ali R, Margiana R, Hjazi A, Alsaab HO, et al. Double-edged sword role of miRNA-633 and miRNA-181 in human cancers. Pathol - Res Pract. 2023;248:154701. https:\/\/doi.org\/10.1016\/j.prp.2023.154701.","journal-title":"Pathol - Res Pract"},{"issue":"5","key":"3843_CR194","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s11596-022-2614-4","volume":"42","author":"HL Li","year":"2022","unstructured":"Li HL, Song YH, Du ZP, Hu YH, Wang ZX, Chen X, et al. Overexpression of MiR-633 suppresses the tumorigenicity of gastric cancer cells and induces apoptosis by targeting MAPK1. Curr Med Sci. 2022;42(5):1033\u201345. https:\/\/doi.org\/10.1007\/s11596-022-2614-4.","journal-title":"Curr Med Sci"},{"key":"3843_CR195","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.1245\/s10434-011-1668-5","volume":"18","author":"Y Wen","year":"2011","unstructured":"Wen Y, Wang Q, Zhou C, Yan D, Qiu G, Yang C, et al. Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery. Ann Surg Oncol. 2011;18:3858\u201367.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"3843_CR196","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1476-4598-8-42","volume":"8","author":"LB Hesson","year":"2009","unstructured":"Hesson LB, Dunwell TL, Cooper WN, Catchpoole D, Brini AT, Chiaramonte R, et al. The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias. Mol Cancer. 2009;8(1):42. https:\/\/doi.org\/10.1186\/1476-4598-8-42.","journal-title":"Mol Cancer"},{"key":"3843_CR197","doi-asserted-by":"publisher","unstructured":"Hossain S, Iwasa H, Sarkar A, Maruyama J, Arimoto-Matsuzaki K, Hata Y. The RASSF6 tumor suppressor protein regulates apoptosis and cell cycle progression via retinoblastoma protein. Mol Cell Biol. 2018;38(17). https:\/\/doi.org\/10.1128\/mcb.00046-18.","DOI":"10.1128\/mcb.00046-18"},{"issue":"11","key":"3843_CR198","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.4161\/15592294.2014.983361","volume":"9","author":"JJ Mezzanotte","year":"2014","unstructured":"Mezzanotte JJ, Hill V, Schmidt ML, Shinawi T, Tommasi S, Krex D, et al. RASSF6 exhibits promoter hypermethylation in metastatic melanoma and inhibits invasion in melanoma cells. Epigenetics. 2014;9(11):1496\u2013503. https:\/\/doi.org\/10.4161\/15592294.2014.983361.","journal-title":"Epigenetics"},{"key":"3843_CR199","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.canlet.2016.12.033","volume":"389","author":"Y Mi","year":"2017","unstructured":"Mi Y, Zhang D, Jiang W, Weng J, Zhou C, Huang K, et al. miR-181a-5p promotes the progression of gastric cancer via RASSF6-mediated MAPK signalling activation. Cancer Lett. 2017;389:11\u201322. https:\/\/doi.org\/10.1016\/j.canlet.2016.12.033.","journal-title":"Cancer Lett"},{"key":"3843_CR200","doi-asserted-by":"publisher","unstructured":"Ouyang M, Liu G, Xiong C, Rao J. microRNA-181a-5p impedes the proliferation, migration, and invasion of retinoblastoma cells by targeting the NRAS proto-oncogene. Clinics. https:\/\/doi.org\/10.1016\/j.clinsp.2022.100026","DOI":"10.1016\/j.clinsp.2022.100026"},{"issue":"12","key":"3843_CR201","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.32604\/or.2024.051569","volume":"32","author":"MA Shadbad","year":"2024","unstructured":"Shadbad MA, Baradaran B. hsa-miR-181a-5p inhibits glioblastoma development via the MAPK pathway: in-silico and in-vitro study. Oncol Res. 2024;32(12):1949\u201358. https:\/\/doi.org\/10.32604\/or.2024.051569.","journal-title":"Oncol Res"},{"issue":"7","key":"3843_CR202","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.prp.2012.05.001","volume":"208","author":"G-s Shu","year":"2012","unstructured":"Shu G-s, Yang Z-l. Liu D-c. Immunohistochemical study of Dicer and drosha expression in the benign and malignant lesions of gallbladder and their clinicopathological significances. Pathology-Research Pract. 2012;208(7):392\u20137.","journal-title":"Pathology-Research Pract"},{"issue":"5","key":"3843_CR203","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1093\/carcin\/bgt022","volume":"34","author":"CV D\u00edaz-Garc\u00eda","year":"2013","unstructured":"D\u00edaz-Garc\u00eda CV, Agudo-Lopez A, Perez C, Lopez-Martin JA, Rodr\u00edguez-Peralto JL, de Castro J, et al. DICER1, DROSHA and MiRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification. Carcinogenesis. 2013;34(5):1031\u20138.","journal-title":"Carcinogenesis"},{"key":"3843_CR204","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1007\/s10620-015-3986-0","volume":"61","author":"H Zhang","year":"2016","unstructured":"Zhang H, Hou Y, Xu L, Zeng Z, Wen S, Du Y-e, et al. Cytoplasmic drosha is aberrant in precancerous lesions of gastric carcinoma and its loss predicts worse outcome for gastric cancer patients. Dig Dis Sci. 2016;61:1080\u201390.","journal-title":"Dig Dis Sci"},{"key":"3843_CR205","doi-asserted-by":"crossref","unstructured":"Farazi TA, Hoell JI, Morozov P, Tuschl T. MicroRNAs in human cancer. MicroRNA cancer regulation: advanced concepts, bioinformatics and systems biology tools. 2013:1\u201320.","DOI":"10.1007\/978-94-007-5590-1_1"},{"issue":"3","key":"3843_CR206","doi-asserted-by":"publisher","first-page":"e2642","DOI":"10.1038\/cddis.2017.5","volume":"8","author":"L Xu","year":"2017","unstructured":"Xu L, Hou Y, Tu G, Chen Y, Du YE, Zhang H, et al. Nuclear drosha enhances cell invasion via an EGFR-ERK1\/2-MMP7 signaling pathway induced by dysregulated miRNA-622\/197 and their targets LAMC2 and CD82 in gastric cancer. Cell Death Dis. 2017;8(3):e2642. https:\/\/doi.org\/10.1038\/cddis.2017.5.","journal-title":"Cell Death Dis"},{"issue":"8","key":"3843_CR207","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/cgt.2010.18","volume":"17","author":"J Ma","year":"2010","unstructured":"Ma J, Dong C, Ji C. MicroRNA and drug resistance. Cancer Gene Ther. 2010;17(8):523\u201331. https:\/\/doi.org\/10.1038\/cgt.2010.18.","journal-title":"Cancer Gene Ther"},{"key":"3843_CR208","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13046-016-0300-8","volume":"35","author":"L Zhao","year":"2016","unstructured":"Zhao L, Wang Y, Jiang L, He M, Bai X, Yu L, et al. MiR-302a\/b\/c\/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP\/ERK kinase kinase 1 (MEKK1). J Exp Clin Cancer Res. 2016;35:25. https:\/\/doi.org\/10.1186\/s13046-016-0300-8.","journal-title":"J Exp Clin Cancer Res"},{"key":"3843_CR209","doi-asserted-by":"publisher","first-page":"120446","DOI":"10.1016\/j.ijpharm.2021.120446","volume":"599","author":"H He","year":"2021","unstructured":"He H, Song F, Gao Q, Lu Z, Yuan Y, Li X, et al. The APEX1\/miRNA-27a-5p axis plays key roles in progression, metastasis and targeted chemotherapy of gastric cancer. Int J Pharm. 2021;599:120446. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120446.","journal-title":"Int J Pharm"},{"issue":"3","key":"3843_CR210","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/nrc3891","volume":"15","author":"LH Pearl","year":"2015","unstructured":"Pearl LH, Schierz AC, Ward SE, Al-Lazikani B, Pearl FM. Therapeutic opportunities within the DNA damage response. Nat Rev Cancer. 2015;15(3):166\u201380.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"3843_CR211","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/onc.2010.435","volume":"30","author":"S Sengupta","year":"2011","unstructured":"Sengupta S, Mantha AK, Mitra S, Bhakat KK. Human AP endonuclease (APE1\/Ref-1) and its acetylation regulate YB-1-p300 recruitment and RNA polymerase II loading in the drug-induced activation of multidrug resistance gene MDR1. Oncogene. 2011;30(4):482\u201393.","journal-title":"Oncogene"},{"issue":"4","key":"3843_CR212","first-page":"484","volume":"20","author":"S Kaur","year":"2018","unstructured":"Kaur S, Ramdzan ZM, Guiot M-C, Li L, Leduy L, Ramotar D, et al. CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent Temozolomide. Neurooncology. 2018;20(4):484\u201393.","journal-title":"Neurooncology"},{"issue":"5","key":"3843_CR213","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.ccell.2016.10.001","volume":"30","author":"HL Sun","year":"2016","unstructured":"Sun HL, Cui R, Zhou J, Teng KY, Hsiao YH, Nakanishi K, et al. ERK activation globally downregulates MiRNAs through phosphorylating Exportin-5. Cancer Cell. 2016;30(5):723\u201336. https:\/\/doi.org\/10.1016\/j.ccell.2016.10.001.","journal-title":"Cancer Cell"},{"issue":"2","key":"3843_CR214","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1161\/circresaha.116.308434","volume":"120","author":"J Viereck","year":"2017","unstructured":"Viereck J, Thum T. Circulating noncoding RNAs as biomarkers of cardiovascular disease and injury. Circ Res. 2017;120(2):381\u201399. https:\/\/doi.org\/10.1161\/circresaha.116.308434.","journal-title":"Circ Res"},{"key":"3843_CR215","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2024-333522","author":"ZR Cai","year":"2025","unstructured":"Cai ZR, Zheng YQ, Hu Y, Ma MY, Wu YJ, Liu J, et al. Construction of exosome non-coding RNA feature for non-invasive, early detection of gastric cancer patients by machine learning: a multi-cohort study. Gut. 2025. https:\/\/doi.org\/10.1136\/gutjnl-2024-333522.","journal-title":"Gut"},{"key":"3843_CR216","doi-asserted-by":"publisher","first-page":"103598","DOI":"10.1016\/j.critrevonc.2022.103598","volume":"171","author":"TS Barwal","year":"2022","unstructured":"Barwal TS, Sharma U, Rana MK, Bazala S, Singh I, Murmu M, et al. A diagnostic and prognostic value of blood-based Circulating long non-coding RNAs in thyroid, pancreatic and ovarian cancer. Crit Rev Oncol\/Hematol. 2022;171:103598. https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103598.","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"6","key":"3843_CR217","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/ncrna10060054","volume":"10","author":"P Papoutsoglou","year":"2024","unstructured":"Papoutsoglou P, Morillon A. Extracellular vesicle LncRNAs as key biomolecules for Cell-to-Cell communication and Circulating cancer biomarkers. Non-Coding RNA. 2024;10(6):54.","journal-title":"Non-Coding RNA"},{"issue":"17","key":"3843_CR218","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.3748\/wjg.v29.i17.2515","volume":"29","author":"T Matsuoka","year":"2023","unstructured":"Matsuoka T, Yashiro M. Novel biomarkers for early detection of gastric cancer. World J Gastroenterol. 2023;29(17):2515\u201333. https:\/\/doi.org\/10.3748\/wjg.v29.i17.2515.","journal-title":"World J Gastroenterol"},{"key":"3843_CR219","doi-asserted-by":"publisher","first-page":"1179582","DOI":"10.3389\/fphys.2023.1179582","volume":"14","author":"I Gareev","year":"2023","unstructured":"Gareev I, Ahmad A, Wang J, Beilerli A, Ilyasova T, Sufianov A, et al. Gastric juice non-coding RNAs as potential biomarkers for gastric cancer. Front Physiol. 2023;14:1179582. https:\/\/doi.org\/10.3389\/fphys.2023.1179582.","journal-title":"Front Physiol"},{"issue":"1","key":"3843_CR220","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1186\/s12864-023-09683-w","volume":"24","author":"CN Thawng","year":"2023","unstructured":"Thawng CN, Smith GB. Transcriptome software results show significant variation among different commercial pipelines. BMC Genomics. 2023;24(1):662. https:\/\/doi.org\/10.1186\/s12864-023-09683-w.","journal-title":"BMC Genomics"},{"issue":"1","key":"3843_CR221","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1161\/atvbaha.116.308513","volume":"37","author":"JE Freedman","year":"2017","unstructured":"Freedman JE, Miano JM. Challenges and opportunities in linking long noncoding RNAs to Cardiovascular, Lung, and blood diseases. Arterioscler Thromb Vasc Biol. 2017;37(1):21\u20135. https:\/\/doi.org\/10.1161\/atvbaha.116.308513.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3843_CR222","doi-asserted-by":"publisher","unstructured":"Hossam Abdelmonem B, Kamal LT, Wardy LW, Ragheb M, Hanna MM, Elsharkawy M, et al. Non-coding rnas: emerging biomarkers and therapeutic targets in cancer and inflammatory diseases. Front Oncol. 2025;15\u20132025. https:\/\/doi.org\/10.3389\/fonc.2025.1534862.","DOI":"10.3389\/fonc.2025.1534862"},{"issue":"1","key":"3843_CR223","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1186\/s13046-022-02467-2","volume":"41","author":"W Mao","year":"2022","unstructured":"Mao W, Wang K, Zhang W, Chen S, Xie J, Zheng Z, et al. Transfection with Plasmid-Encoding lncRNA-SLERCC nanoparticle-mediated delivery suppressed tumor progression in renal cell carcinoma. J Experimental Clin Cancer Res. 2022;41(1):252. https:\/\/doi.org\/10.1186\/s13046-022-02467-2.","journal-title":"J Experimental Clin Cancer Res"},{"key":"3843_CR224","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/978-1-60761-863-8_15","volume":"676","author":"Z Wang","year":"2011","unstructured":"Wang Z. The guideline of the design and validation of MiRNA mimics. Methods Mol Biol. 2011;676:211\u201323. https:\/\/doi.org\/10.1007\/978-1-60761-863-8_15.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"3843_CR225","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.bbrc.2018.08.158","volume":"504","author":"T Yamazaki","year":"2018","unstructured":"Yamazaki T, Fujikawa C, Kubota A, Takahashi A, Hirose T. CRISPRa-mediated NEAT1 LncRNA upregulation induces formation of intact paraspeckles. Biochem Biophys Res Commun. 2018;504(1):218\u201324. https:\/\/doi.org\/10.1016\/j.bbrc.2018.08.158.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"3843_CR226","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s41232-024-00358-x","volume":"44","author":"SH Zhang","year":"2024","unstructured":"Zhang SH, Peng LL, Chen YF, Xu Y, Moradi V. Focusing on exosomes to overcome the existing bottlenecks of CAR-T cell therapy. Inflamm Regen. 2024;44(1):45. https:\/\/doi.org\/10.1186\/s41232-024-00358-x.","journal-title":"Inflamm Regen"},{"issue":"1","key":"3843_CR227","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s43586-022-00104-y","volume":"2","author":"BB Mendes","year":"2022","unstructured":"Mendes BB, Conniot J, Avital A, Yao D, Jiang X, Zhou X, et al. Nanodelivery of nucleic acids. Nat Reviews Methods Primers. 2022;2(1):24. https:\/\/doi.org\/10.1038\/s43586-022-00104-y.","journal-title":"Nat Reviews Methods Primers"},{"key":"3843_CR228","doi-asserted-by":"publisher","unstructured":"Dehghan F, Metanat Y, Askarizadeh M, Ahmadi E, Moradi V. Novel gene manipulation approaches to unlock the existing bottlenecks of CAR-NK cell therapy. Front Cell Dev Biology. 2025;12\u20132024. https:\/\/doi.org\/10.3389\/fcell.2024.1511931.","DOI":"10.3389\/fcell.2024.1511931"},{"key":"3843_CR229","doi-asserted-by":"publisher","first-page":"1388475","DOI":"10.3389\/fonc.2024.1388475","volume":"14","author":"V Moradi","year":"2024","unstructured":"Moradi V, Khodabandehloo E, Alidadi M, Omidkhoda A, Ahmadbeigi N. Progress and pitfalls of gene editing technology in CAR-T cell therapy: a state-of-the-art review. Front Oncol. 2024;14:1388475. https:\/\/doi.org\/10.3389\/fonc.2024.1388475.","journal-title":"Front Oncol"},{"issue":"12","key":"3843_CR230","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1080\/15476286.2021.1899500","volume":"18","author":"MSZ Hartford","year":"2021","unstructured":"Hartford MSZ, Lal CCR. Interrogating LncRNA functions via CRISPR\/Cas systems. RNA Biol. 2021;18(12):2097\u2013106. https:\/\/doi.org\/10.1080\/15476286.2021.1899500.","journal-title":"RNA Biol"},{"key":"3843_CR231","doi-asserted-by":"publisher","unstructured":"Collotta D, Bertocchi I, Chiapello E, Collino M. Antisense oligonucleotides: a novel frontier in Pharmacological strategy. Front Pharmacol. 2023;14\u20132023. https:\/\/doi.org\/10.3389\/fphar.2023.1304342.","DOI":"10.3389\/fphar.2023.1304342"},{"key":"3843_CR232","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.omtn.2018.04.003","volume":"11","author":"C Chen","year":"2018","unstructured":"Chen C, Yue D, Lei L, Wang H, Lu J, Zhou Y, et al. Promoter-Operating targeted expression of gene therapy in cancer: current stage and prospect. Mol Ther Nucleic Acids. 2018;11:508\u201314. https:\/\/doi.org\/10.1016\/j.omtn.2018.04.003.","journal-title":"Mol Ther Nucleic Acids"},{"key":"3843_CR233","doi-asserted-by":"publisher","unstructured":"Kallunki T, Barisic M, J\u00e4\u00e4ttel\u00e4 M, Liu B. How to choose the right inducible gene expression system for mammalian studies? Cells. 2019;8(8). https:\/\/doi.org\/10.3390\/cells8080796.","DOI":"10.3390\/cells8080796"},{"issue":"3","key":"3843_CR234","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s11523-020-00717-x","volume":"15","author":"M Ratti","year":"2020","unstructured":"Ratti M, Lampis A, Ghidini M, Salati M, Mirchev MB, Valeri N, et al. MicroRNAs (miRNAs) and long Non-Coding RNAs (lncRNAs) as new tools for cancer therapy: first steps from bench to bedside. Target Oncol. 2020;15(3):261\u201378. https:\/\/doi.org\/10.1007\/s11523-020-00717-x.","journal-title":"Target Oncol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03843-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03843-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03843-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T11:07:54Z","timestamp":1762168074000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03843-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":234,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3843"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03843-y","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"21 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2007"}}